GovWire

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

Medicines Healthcare Products Regulatory Agency

September 14
09:34 2022

MDR Number

MDR 025-09/22

Company name

Rosemont Pharmaceuticals Ltd.

Product description

Atorvastatin 4mg/ml Oral Suspension PL 00427/0256

Batch Number Expiry Date Pack Size First Distributed
ATV21001 Apr-2024 150 ml 28-Apr-2022
ATV21002 Apr-2024 150 ml 13-Jul-2022

Active Pharmaceutical Ingredient: Atorvastatin

Sildenafil 10mg/ml Oral Suspension PL 00427/0258

Batch Number Expiry Date Pack Size First Distributed
SLD22001 Mar-2025 122 ml Not yet distributed
SLD22002 Apr-2025 122 ml 22-Jun-2022

Active Pharmaceutical Ingredient: Sildenafil

Brief description of the problem

Rosemont Pharmaceuticals Ltd. has made the MHRA aware that the expiry dates stamped on the base of the bottle are incorrect for the above 2 batches of Atorvastatin 4mg/ml Oral Suspension (indicated for hypercholesterolaemia and prevention of cardiovascular disease) and 2 batches of Sildenafil 10mg/ml Oral Suspension (indicated for pulmonary arterial hypertension). The correct expiry dates (as stated in the above table) are printed on the bottle label and on the outer carton. All other product details are correct, including the serial numbers and batch numbers.

Advice for healthcare professionals

There is no risk to product quality as a result of this issue, therefore the affected batches are not being recalled. Healthcare professionals should advise patients of the issue when dispensing these products. The products can be used until the expiry date printed on the bottle label and the outer carton. The expiry date stamped on the base of the bottle should be ignored. No other batches of Atorvastatin 4mg/ml Oral Suspension or Sildenafil 10mg/ml Oral Suspension marketed by Rosemont Pharmaceuticals are affected by this discrepancy.

Advice for patients

Patients should note that the expiry date printed on the base of the bottle for these products is incorrect and should be ignored. There are no concerns about the safety or quality of the medicine. The expiry date is correct on the bottle label and the outer carton (box). Patients should use these products until the expiry date on the bottle label and outer carton. If a patient has any concerns, they should contact their pharmacist.

Further Information

For further information please contact: pharmacovigilance@rosemontpharma.com

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Yours faithfully

Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU

Telephone +44 (0)20 3080 6574

DMRC@mhra.gov.uk

Download document

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

Published 14 September 2022

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: